BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
60
$0.58
$35
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
6,188
$3.85
$23,824
Sale
SPUDICH JAMES Adirectordirector
Common Stock
3,000
$5.69
$17,055
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$5.71
$39,970
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$1.2
$8,400
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$1.2
$8,400
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,775
$5.87
$33,870
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$6
$30,000
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
27,500
$1.2
$33,000
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
4,950
$6.46
$31,977
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
27,500
$1.2
$33,000
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$0.89
$6,230
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$6.4
$44,807
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$0.89
$6,230
Sale
SPUDICH JAMES Adirectordirector
Common Stock
3,000
$6.52
$19,560
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
3,300
$6.5
$21,460
Sale
SPUDICH JAMES Adirectordirector
Common Stock
3,000
$6.68
$20,040
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,500
$7.01
$10,515
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,500
$7.05
$10,580
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,500
$7.12
$10,680
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,500
$8
$12,000
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$8
$55,965
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$1.2
$8,400
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$1.2
$8,400
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
5,000
$1.2
$6,000
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$8.32
$18,293
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,000
$8.3
$8,300
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$1.2
$8,400
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$8.7
$60,893
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$1.2
$8,400
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$6.83
$15,033
Sale
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$0.58
$2,900
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$0.58
$2,900
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
5,000
$1.2
$6,000
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
5,000
$0.58
$2,900
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Common Stock
5,000
$1.2
$6,000
Sale
TRAUTMAN JAY Kofficer: VP, Discovery Researchofficer: VP, Discovery Research
Common Stock
1,000
$7.3
$7,300
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$0.89
$6,230
Sale
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Common Stock
7,000
$7.4
$51,828
Option
SABRY JAMES Hother: Former Executive Chairmanother: Former Executive Chairman
Non-Qualified Stock Option (right to buy)
7,000
$0.89
$6,230
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$7.29
$36,450
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Incentive Stock Option (right to buy)
5,000
$0.58
$2,900
Option
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$0.58
$2,900
Sale
SPUDICH JAMES Adirectordirector
Common Stock
2,200
$7.73
$17,013
Option
MORGANS DAVID J JRofficer: EVP-Preclinical R&Dofficer: EVP-Preclinical R&D
Incentive Stock Option (right to buy)
5,000
$1.2
$6,000
Sale
BLUM ROBERT Idirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$0.58
$2,900
Showing 1050 to 1100 of 1267 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.